DORADO, Puerto Rico, April 09, 2019 (GLOBE
NEWSWIRE) -- GSRX Industries Inc. (GSRX)
(âGSRXâ or the âCompanyâ) announced today that it has purchased
Units representing membership interests in Buzznog, LLC, which owns
and operates Buzznog, a direct-to-fan social media platform for
live events and activations. Buzznog provides powerful
solutions for established and emerging artists, festivals, and
brands. In addition to its cutting-edge technologies for live
events, music releases and fan engagement Buzznog creates
hyper-focused targeted initiatives to deliver the right content at
the right time to the right audience.
âTaking this position in Buzznog is a great investment for our company,â said GSRX CEO Les Ball. âBuzznog is the hottest app weâve seen for music fans, and we are glad to be early investors at a point where it is about to grow exponentially.â
Added Buzznog CEO Phil Elias, âWe welcome GSRXâs investment in Buzznog, and especially their confidence in what we have built. 2019 is poised to be a great year for us as we expand our universe of artist access and fan engagement via our uniquely branded mobile app.â
Buzznog counts among its clients Rolling Loud Music Festival, Breakaway Music Festival, Warner Music Group, Universal Music Group, Big Machine, and Madison Square Garden Company.
About GSRX Industries
GSRX
Industries Inc. (GSRX), through its
subsidiaries, is in the business of acquiring, developing and
operating retail cannabis dispensaries and non-THC CBD retail
stores. GSRX is also in the process of expanding
its business to include distribution, lite manufacturing and
delivery of cannabis and cannabinoid
products. Currently, GSRX operates five cannabis
dispensaries in Puerto Rico under the name Green Spirit RX, one
dispensary in California under the name The Green Room, and has
five additional pre-qualified locations in Puerto Rico, all of
which are in various phases of development and construction.
GSRX also owns and operates the e-commerce site GetPureAndNatural.com,
which offers a broad range of pharmaceutical grade CBD
products.
About Buzznog
Buzznog is a
global social engagement platform connecting artists with their
super-fans. An interactive social community is created for each
artist via a uniquely branded mobile app that creates meaningful
micro-moment experiences for fans through real-time access to
over-the-top (OTT) content. Extensive fan
data points are captured to provide not only demographic and
psychographic information to the artist but also content
interaction within the community. Monetary transactions are
recorded within the app allowing artists to gain visibility to
items such as merchandise purchases, ticket sales, and subscription
revenue on a per fan basis. Combining engagement and monetary data
allows the artist to create hyper-focused fan
experiences.
Forward-Looking
Statements
This press release contains
forward-looking statements. Such statements include statements
regarding the Companyâs expectations, hopes, beliefs or intentions
regarding the future, including but not limited to statements
regarding our market, strategy, competition, development plans
(including acquisitions and expansion), financing, anticipated
revenues, operations, and compliance with applicable laws.
Forward-looking statements involve certain risks and uncertainties,
and actual results may differ materially from those discussed in
any such statement. Factors that could cause actual results to
differ materially from such forward-looking statements include the
risks described in greater detail in the following paragraphs. All
forward-looking statements in this document are made as of the date
hereof, based on information available to us as of the date hereof,
and we assume no obligation to update any forward-looking statement
except where applicable law requires us to update these statements.
Market data used throughout this prospectus is based on published
third party reports or the good faith estimates of management,
which estimates are based upon their review of internal surveys,
independent industry publications and other publicly available
information.
Contact:
Paul Gendreau
PGPR
[email protected]
678-807-7945